E-LIB Suche - Ergebnisse für: Sprick, Martin Ronald

1

Protocol of the IntenSify‐Trial: An open‐label phase I tria..:

Hohmann, Nicolas ; Sprick, Martin Ronald ; Pohl, Moritz...
Clinical and Translational Science. 16 (2023) 12 - p. 2483-2493 , 2023

Link: https://doi.org/10.1111/..

2

The sialyl-glycolipid stage-specific embryonic antigen 4 ma..:

Aloia, Andrea ; Petrova, Evgeniya ; Tomiuk, Stefan...
Breast Cancer Research. 17 (2015) 1 - p. , 2015

Link: https://doi.org/10.1186/..

3

The impact of HER2 phenotype of circulating tumor cells in ..:

Wallwiener, Markus ; Hartkopf, Andreas Daniel ; Riethdorf, Sabine...
BMC Cancer. 15 (2015) 1 - p. , 2015

Link: https://doi.org/10.1186/..

4

Serial enumeration of circulating tumor cells predicts trea..:

Wallwiener, Markus ; Riethdorf, Sabine ; Hartkopf, Andreas Daniel...
BMC Cancer. 14 (2014) 1 - p. , 2014

Link: https://doi.org/10.1186/..

5

Protocol of the IntenSify‐Trial: An open‐label phase I tria..:

Hohmann, Nicolas ; Sprick, Martin Ronald ; Pohl, Moritz...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10719473/. , 2023

Link: http://www.ncbi.nlm.nih...

6

The impact of HER2 phenotype of circulating tumor cells in ..:

Wallwiener, Markus ; Hartkopf, Andreas Daniel ; Riethdorf, Sabine...
https://archiv.ub.uni-heidelberg.de/volltextserver/19349/1/12885_2015_Article_1423.pdf. , 2015

Link: https://archiv.ub.uni-he..

7

The sialyl-glycolipid stage-specific embryonic antigen 4 ma..:

Aloia, Andrea ; Petrova, Evgeniya ; Tomiuk, Stefan...
info:eu-repo/semantics/altIdentifier/pmid/26607327. , 2015

Link: http://hdl.handle.net/11..

8

Bortezomib Sensitizes Primary Meningioma Cells to TRAIL-Ind..:

Koschny, Ronald ; Boehm, Christina ; Sprick, Martin R....
Journal of Neuropathology & Experimental Neurology. 73 (2014) 11 - p. 1034-1046 , 2014

Link: https://doi.org/10.1097/..

9

TRAIL/bortezomib cotreatment is potentially hepatotoxic but..:

Koschny, Ronald ; Ganten, Tom M. ; Sykora, Jaromir...
Hepatology. 45 (2007) 3 - p. 649-658 , 2007

Link: https://doi.org/10.1002/..

10

Diagnostic leukapheresis reveals distinct phenotypes of NSC..:

Rieckmann, Lisa-Marie ; Spohn, Michael ; Ruff, Lisa...
Molecular Cancer. 23 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

11

Protocol of the IntenSify‐Trial: An open‐label phase I tria..:

Nicolas Hohmann ; Martin Ronald Sprick ; Moritz Pohl...
https://doi.org/10.1111/cts.13661. , 2023

Link: https://doi.org/10.1111/..

12

Resistance to mesenchymal reprogramming sustains clonal pro..:

Saini, Massimo ; Schmidleitner, Laura ; Moreno, Helena Domínguez...
Cell Reports. 42 (2023) 6 - p. 112533 , 2023

Link: https://doi.org/10.1016/..

13

Therapy resistance on the RADar in ovarian cancer:

Schwickert, Jonas ; Zickgraf, Franziska M ; Sprick, Martin R
EMBO Molecular Medicine. 13 (2021) 5 - p. , 2021

Link: https://doi.org/10.15252..

14

Single cell polarity in liquid phase facilitates tumour met..:

Lorentzen, Anna ; Becker, Paul F. ; Kosla, Jan...
Nature Communications. 9 (2018) 1 - p. , 2018

Link: https://doi.org/10.1038/..

15

Saa3 is a key mediator of the protumorigenic properties of ..:

Djurec, Magdolna ; Graña, Osvaldo ; Lee, Albert...
Proceedings of the National Academy of Sciences. 115 (2018) 6 - p. , 2018

Link: https://doi.org/10.1073/..